Royce & Associates LP’s Transmedics Group Inc Position
Does Royce & Associates LP own Transmedics Group Inc (TMDX)? Yes — 244.4K shares worth $24M (+0.24% of its 13F portfolio) as of Q1 2026, up from 243.1K shares the prior filed quarter.
Position Value
$24M
Q1 2026
Shares
244.4K
% of Portfolio
+0.24%
Quarters Held
19
currently held
Position History TMDX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 244.4K | $24M | +0.24% |
| Q4 2025 | 243.1K | $30M | +0.30% |
| Q3 2025 | 243.1K | $27M | +0.27% |
| Q2 2025 | 247.4K | $33M | +0.34% |
| Q1 2025 | 297.2K | $20M | +0.22% |
| Q4 2024 | 297.2K | $19M | +0.17% |
| Q3 2024 | 297.2K | $47M | +0.42% |
| Q2 2024 | 301.2K | $45M | +0.42% |
| Q1 2024 | 315.2K | $23M | +0.21% |
| Q4 2023 | 351.7K | $28M | +0.26% |
| Q3 2023 | 141.7K | $8M | +0.08% |
| Q2 2023 | 137.5K | $12M | +0.11% |
| Q1 2023 | 159.5K | $12M | +0.12% |
| Q4 2022 | 192.0K | $11,850 | +0.12% |
| Q3 2022 | 152.0K | $6M | +0.07% |
| Q2 2022 | 142.0K | $4M | +0.05% |
| Q1 2022 | 87.0K | $2M | +0.02% |
| Q4 2021 | 61.0K | $1M | +0.01% |
| Q3 2020 | 41.0K | $565,000 | +0.01% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Royce & Associates LP’s full portfolio or all institutional holders of TMDX.